TACI

TACI 분자 정보

영어 이름Tumor necrosis factor receptor superfamily member 13B시판 약물 수0
임상 약물 수0표적 별명Transmembrane activator and CAML interactor,CD267,TACI
최고 연구 개발 단계Preclinical
영어 이름Tumor necrosis factor receptor superfamily member 13B
표적 별명Transmembrane activator and CAML interactor,CD267,TACI
시판 약물 수0
임상 약물 수0
최고 연구 개발 단계Preclinical

TACI 제품 목록

  • 속성

    Protein (6)Cell (1)

  • 제품 라이브러리

    온라인 (7)

  • Human (7)

  • 태그

    Fc Tag & Avi Tag (1)Fc Tag (2)His Tag (1)- (2)His Tag & Avi Tag (1)

  • 마커

    Biotin-labeled (3)Unconjugated (3)- (1)

TACI분자 배경

Transmembrane activator and CAML interactor (TACI), also known as tumor necrosis factor receptor superfamily member 13B (TNFRSF13B). It was originally discovered because of its ability to interact with calcium-modulator and cyclophilin ligand (CAML). TACI was later found to play a crucial role in humoral immunity by interacting with two members of the TNF family: BAFF and APRIL. The present study demonstrated that, in NSCLC, a proliferation-inducing ligand (APRIL), B-cell maturation antigen (BCMA)and transmembrane activator and CAML interactor (TACI) proteins are abnormally expressed by immunohistochemistry, reverse transcription-quantitative polymerase chain reaction and western blotting. In addition, the expression of APRIL, BCMA and TACI were observed to be involved in extracellular signal-regulated kinase (ERK)1/2 activation in A549 cells.

TACI분자 별명

CD267,TACI,TNFRSF13B
  • 분자 정보
  • 제품 목록
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호